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In the article titled 'Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers', there is the following errors:

In the abstract, the sentence 'Among twenty-one key genes involving in the regulation of DNA methylation, TET1-mutant (TET1-MUT) was enriched in patients responding to ICI treatment in the discovery cohort (p\<0.001)' should instead read 'Among twenty-one key genes involving in the regulation of DNA methylation, TET1-mutant (TET1-MUT) was enriched in patients responding to ICI treatment in the discovery cohort (p=0.003)'

Additionally, in Figure 6:

1.  Line 5, 'HLA-DQA1' should be 'HLA-DQA2'

2.  Line 51--69 (from ENDRB to TIGIT), the category of these genes 'Other' should be 'Receptor'

3.  Line 70--75 (from ARG1 to PRF1), the category of these genes 'Receptor' should be 'Other'.

The correct Figure 6 can be seen below:
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